BRAF and neoplasm: The expression of mutated Braf within the B16 tumor cells may have affected levels of FAP+ cells, as a different B16.F10 tumor with wild-type Braf but modified to express GFP had markedly higher percentages of FAP+ cells (~ 25%, data not shown).